BakitasMA, TostesonTD, LiZ, et al.: Early versus delayed initiation of concurrent palliative oncology care: Patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol, 2015; 33:1438–1445.
2.
TemelJS, GreerJA, MuzikanskyA, et al.: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 2010; 363:733–742.
3.
MayP, NormandC, MorrisonRS: Economic impact of hospital inpatient palliative care consultation: Review of current evidence and directions for future research. J Palliat Med, 2014; 17:1054–1063.
4.
LangtonJM, BlanchB, DrewAK, et al.: Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review. Palliat Med, 2014; 28:1167–1196.
5.
GreerJA, TramontanoAC, McMahonPM, et al.: Cost analysis of a randomized trial of early palliative care in patients with metastatic nonsmall-cell lung cancer. J Palliat Med, 2016; 19:842–848.
6.
EarleCC, AyanianJZ: Looking back from death: The value of retrospective studies of end-of-life care. J Clin Oncol, 2006; 24:838–840.
7.
RoundJ: Is a QALY still a QALY at the end of life?. J Health Econ, 2012; 31:521–527.
8.
CoastJ: Strategies for the economic evaluation of end-of-life care: Making a case for the capability approach. Expert Rev Pharmacoecon Outcomes Res, 2014; 14:473–482.
9.
SmithS, BrickA, O'HaraS, et al.: Evidence on the cost and cost-effectiveness of palliative care: A literature review. Palliat Med, 2014; 28:130–150.
10.
MalhotraC, FarooquiMA, KanesvaranR, et al.: Comparison of preferences for end-of-life care among patients with advanced cancer and their caregivers: A discrete choice experiment. Palliat Med, 2015; 29:842–850.
11.
BauseweinC, DavesonBA, BenaliaH, et al.: Outcome measurement in palliative care: The essentials. In: HardingR (ed): PRISMA. London: King's College London, 2011.
